Literature DB >> 9383596

History of echocardiographic contrast agents.

N C Nanda1.   

Abstract

Since its experimental introduction over 30 years ago, the use of cardiac ultrasound has expanded expeditiously, particularly in the last decade. The inception of managed care has fueled this expansion because ultrasound technology has the potential to enhance cost-effective diagnosis and medical care. Another important factor driving the growth of cardiac ultrasound has been the recent and rapid development of contrast echocardiography (CE). This diagnostic technique, involving the injection of a contrast agent to enhance ultrasound imaging, provides a safe, noninvasive means of directly assessing myocardial perfusion and a host of other aspects of cardiovascular health and integrity.

Mesh:

Substances:

Year:  1997        PMID: 9383596     DOI: 10.1002/clc.4960201304

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  8 in total

Review 1.  The clinical use of contrast-enhanced ultrasound in the kidney.

Authors:  Sean C Tenant; Catherine M Gutteridge
Journal:  Ultrasound       Date:  2016-01-19

2.  Preserving the Integrity of Surfactant-Stabilized Microbubble Membranes for Localized Oxygen Delivery.

Authors:  Brian E Oeffinger; Purva Vaidya; Iman Ayaz; Rawan Shraim; John R Eisenbrey; Margaret A Wheatley
Journal:  Langmuir       Date:  2019-03-14       Impact factor: 3.882

Review 3.  Perspective on ultrasound bioeffects and possible implications for continuous post-dive monitoring safety.

Authors:  Erica P McCune; David Q Le; Peter Lindholm; Kathryn R Nightingale; Paul A Dayton; Virginie Papadopoulou
Journal:  Diving Hyperb Med       Date:  2022-06-30       Impact factor: 1.228

Review 4.  Ultrasound contrast agents: microbubbles made simple for the pediatric radiologist.

Authors:  Anush Sridharan; John R Eisenbrey; Flemming Forsberg; Norbert Lorenz; Ludwig Steffgen; Aikaterini Ntoulia
Journal:  Pediatr Radiol       Date:  2021-06-12

Review 5.  Emerging Applications of Ultrasound-Contrast Agents in Radiation Therapy.

Authors:  Quezia Lacerda; Mohamed Tantawi; Dennis B Leeper; Margaret A Wheatley; John R Eisenbrey
Journal:  Ultrasound Med Biol       Date:  2021-02-27       Impact factor: 3.694

Review 6.  Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications.

Authors:  Andrew W Appis; Melissa J Tracy; Steven B Feinstein
Journal:  Echo Res Pract       Date:  2015-04-22

7.  The contrast-enhanced Doppler ultrasound with perfluorocarbon exposed sonicated albumin does not improve the diagnosis of renal artery stenosis compared with angiography.

Authors:  Odila U N Teixeira; Luiz A Bortolotto; Hélio Bernardes Silva
Journal:  J Negat Results Biomed       Date:  2004-09-20

8.  Cavitation-threshold Determination and Rheological-parameters Estimation of Albumin-stabilized Nanobubbles.

Authors:  Maxime Lafond; Akiko Watanabe; Shin Yoshizawa; Shin-Ichiro Umemura; Katsuro Tachibana
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.